Abstract: A wireless device has at least a first modem and a second modem and at least a first SIM and a second SIM. The first modem supports a different level of service than the second modem. A processing system of the wireless device selectively reconfigures the connection of the first modem and the second modem to the SIMs. In a first mapping configuration, the first SIM is connected to the first modem and the second SIM is connected to the second modem. In a second mapping configuration, the second SIM is disconnected from the second modem, and the first SIM is disconnected from the first modem and is connected to the second modem thereby to obtain a different level of service for the first SIM than in the first mapping configuration.

Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode methyltransferase polypeptides from a Papaver somniferum cultivar; and uses in the production of noscapine and identification of poppy cultivars that include the genes that comprise said nucleic acid molecules.

Abstract: A wireless device has a first SIM and a second SIM. The first SIM and the second SIM share a common radio system. A processing system determines whether to allocate use of the radio system to the second SIM for a time period that occurs when the first SIM is in an active connected mode using the common radio system in order to be able to at least one of transmit data and receive data. The processing system allocates or denies use of the radio system to the second SIM accordingly.

Abstract: A user equipment UE determines that a neighbor cell is higher priority than a serving cell, measures neighbor cell signal strength in n>1 iterations, and analyzes them for reselecting from the serving cell to the neighbor cell. Each measurement iteration is spaced from one another by a time interval (e.g., 1 DRX) that is specific for the neighbor cell being higher priority. In various embodiments, the UE measures while in a Cell-PCH, URA-PCH or idle state/mode and the first iteration is taken at the first available measurement opportunity after transitioning to that state/mode. The UE reselects to the neighbor cell based on the analyzed signal strengths; in one embodiment the decision to reselect is without regard to signal quality of the serving cell; and in another the decision is without regard to whether a reselection condition remains satisfied for a specified time period Treselection.

Abstract: A user equipment UE determines that a neighbor cell is higher priority than a serving cell, measures neighbor cell signal strength in n>1 iterations, and analyzes them for reselecting from the serving cell to the neighbor cell. Each measurement iteration is spaced from one another by a time interval (e.g., 1 DRX) that is specific for the neighbor cell being higher priority. In various embodiments, the UE measures while in a Cell-PCH, URA-PCH or idle state/mode and the first iteration is taken at the first available measurement opportunity after transitioning to that state/mode. The UE reselects to the neighbor cell based on the analyzed signal strengths; in one embodiment the decision to reselect is without regard to signal quality of the serving cell; and in another the decision is without regard to whether a reselection condition remains satisfied for a specified time period Treselection.

Abstract: A user equipment UE determines that a neighbor cell is higher priority than a serving cell, measures neighbor cell signal strength in n>1 iterations, and analyzes them for reselecting from the serving cell to the neighbor cell. Each measurement iteration is spaced from one another by a time interval (e.g., 1 DRX) that is specific for the neighbor cell being higher priority. In various embodiments, the UE measures while in a Cell-PCH, URA-PCH or idle state/mode and the first iteration is taken at the first available measurement opportunity after transitioning to that state/mode. The UE reselects to the neighbor cell based on the analyzed signal strengths; in one embodiment the decision to reselect is without regard to signal quality of the serving cell; and in another the decision is without regard to whether a reselection condition remains satisfied for a specified time period Treselection.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases, including cathepsins B, K, C, F, H, L, O, S, W and X. Of particular interest are diseases associated with Cathepsin K.

Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds and 2,6,9,13- and 2,6,10,13-tetrasubstituted compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. These features are enhanced by ?-? parallel stacking in the solid state. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.

Abstract: We describe a plant and plant cell which is modified to enhance the production of plant-derived oil in particular in non-seed tissue and including methods for the processing of plant derived biomass materials.

Abstract: In one exemplary embodiment of the invention, a method includes: detecting a local network access node; generating a measurement report based on the detected local network access node, where the measurement report is for transmission to a serving network access node; and in response to successfully reading system information for the detected local network access node, including in the generated measurement report information that uniquely identifies the detected local network access node.

Abstract: An apparatus for providing ciphering problem detection may include a processor. The processor may be configured to receive an unacknowledged mode message, initiate operation of a timer based on receipt of the unacknowledged mode message, re-initiate timer operation in response to each subsequent unacknowledged mode message received prior to expiration of the timer, record a timer expiry event in response to the timer expiring prior to receipt of a subsequent unacknowledged mode message, and indicate a data reception error in response to receipt of the subsequent unacknowledged mode message after recordation of the timer expiry event.

Abstract: This invention relates to nucleic acid molecules which comprise nucleic acid sequences which encode enzymes involved in the biosynthesis of n-3 fatty acids, particularly docosahexanoic acid (DHA), or variants thereof; polypeptides encoded by said nucleic acids; cells transfected with said nucleic acid sequences and products comprising said nucleic acid sequences, polypeptides and/or cells.

Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.

Abstract: The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed permit the production of 2,9- and 2,10-disubstituted pentacene compounds and 2,6,9,13- and 2,6,10,13-tetrasubstituted compounds that present particularly advantageous properties for the manufacture of semiconductor materials, and may be used in devices such as for example thin film transistors and solar cells. These features are enhanced by ?-? parallel stacking in the solid state. Also disclosed are compounds that are excellent candidates for use in the manufacture of semiconductor materials, and other components of electronic systems, by virtue of their solubility, crystal packing geometries, and electronic properties.

Abstract: The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R1, R2, R3, R4 and R5 are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.

Abstract: We describe a method for the detection of triacylglycerols (TAGs) in a biological sample.

Abstract: We describe a transgenic plant with altered expression of a gene that encodes a sequence variant of a transcription factor and which has altered seed dormancy.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases, including cathepsins B, K, C, F, H, L, O, S, W and X. Of particular interest are diseases associated with Cathepsin K.

Abstract: The invention provides methods, nucleic acids and kits for detecting, classifying and/or distinguishing between or among lung cell proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients.

Abstract: The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R1, R2, R3, R4 and R5 are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.